Auryxia
Brand for: Ferric citrate
My Prescription
Payment
Select pharmacy
$108.90
Print or send this coupon to your phone
AlbertsonsPowered byAbout Auryxia
Drug Details
Ferric citrate, marketed as Auryxia, is a medication used to manage high phosphate levels in adults with chronic kidney disease on dialysis, as well as to address iron-deficiency anemia in those with chronic kidney disease not on dialysis. This drug functions as a phosphate binder by attaching to the phosphorus in the food you consume, preventing its absorption into the bloodstream and aiding its elimination through waste. By reducing phosphate levels, it helps protect bones and reduce the risk of mineral buildup that can lead to heart disease and strokes. Additionally, ferric citrate serves as an iron supplement, essential for producing red blood cells and maintaining overall health. It is available in 210 mg tablets, taken orally three times daily with meals. Common side effects include dark stools, diarrhea, and constipation. Always consult your healthcare provider for personalized medical advice before starting any new medication.
Price history for Auryxia (brand) & Ferric Citrate (generic)
90 Tablets, 1 GM210 MG(Fe)
Average retail price for Auryxia
Average retail price for Ferric Citrate
Average SaveHealth price for Ferric Citrate
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
Over the last 12 months, the average discount price of Auryxia is $512.99 using the SaveHealth savings card. That's an average savings of 73.13% on Auryxia with our discount card.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Auryxia (Ferric Citrate) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 1 GM210 MG(Fe) | 90 Tablets | $376.43 | $4.18 |
| 1 GM210 MG(Fe) | 200 Tablets | $798.26 | $3.99 |
Auryxia FAQs
Auryxia is used to treat hyperphosphatemia, which is an elevated level of phosphate in the blood, in patients with chronic kidney disease on dialysis. It is also used to treat iron deficiency anemia in adults with chronic kidney disease who are not on dialysis.
Auryxia and sevelamer are not the same. Auryxia contains ferric citrate and is used to control serum phosphorus levels in patients with chronic kidney disease on dialysis, as well as to treat iron deficiency anemia in patients with chronic kidney disease not on dialysis. Sevelamer, on the other hand, is a phosphate binder used to control phosphorus levels in patients with chronic kidney disease on dialysis. They have different active ingredients and mechanisms of action.
Yes, Auryxia (ferric citrate) can cause black stools. This is a common side effect due to the iron content in the medication. If there are any concerns about this or other side effects, it is advisable to consult a healthcare professional.
An alternative to Auryxia (ferric citrate) for managing hyperphosphatemia in patients with chronic kidney disease on dialysis could be other phosphate binders such as sevelamer (Renvela or Renagel), lanthanum carbonate (Fosrenol), or calcium acetate (PhosLo). It is important for patients to consult with their healthcare provider to determine the most appropriate treatment option based on their specific medical condition and needs.
Yes, Auryxia is an iron-based medication used to manage phosphorus levels in patients with chronic kidney disease on dialysis. It also provides iron supplementation to help treat iron deficiency anemia in patients with chronic kidney disease not on dialysis.